Changes and significance of inflammatory cytokines in a rat model of cervical spondylosis

Yin,Jianjian; Huang,Yongjing; Gao,Gongming; Nong,Luming; Xu,Nanwei; Zhou,Dong

doi:10.3892/etm.2017.5418

Changes and significance of inflammatory cytokines in a rat model of cervical spondylosis

Authors:
- Jianjian Yin
- Yongjing Huang
- Gongming Gao
- Luming Nong
- Nanwei Xu
- Dong Zhou
View Affiliations

Affiliations: Department of Orthopedics, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, Jiangsu 213003, P.R. China
Published online on: November 1, 2017 https://doi.org/10.3892/etm.2017.5418
Pages: 400-406

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to dynamically observe and discuss the significance of inflammatory cytokines in cervical degenerative disease induced by unbalanced dynamic and static forces in rats. A total of 60 Sprague Dawley rats were randomized into test (n=45) and control (n=15) groups, which were randomly subdivided into three groups corresponding to assessment at one, three and six months post‑operation. The test group included 10, 15 and 20 rats at the corresponding post‑operative stage and the control group had five rats at each time‑point. By excising cervicodorsal muscles and ligaments, an unbalanced dynamic and static rat model was established in the test group. At one, three and six‑months post‑operation, venous serum of test and control group rats was collected and inflammatory cytokines in the serum of all rats were quantitatively determined by ELISA. The results revealed that compared with the control group, the interleukin (IL)‑1β, IL‑10 and tumor necrosis factor‑α levels in the test group were significantly increased at one and three months (P<0.05, <0.01 or <0.001), and that IL‑12 was significantly increased at three months (P<0.05). However, transforming growth factor‑β1 increased at one month but was significantly decreased at three months (P<0.01). IL‑6 did not change significantly throughout the observation period (P>0.05). In conclusion, cervical vertebral stability may be accompanied with changes of inflammatory cytokines.

View Figures

View References

1	Miyamoto S, Yonenobu K and Ono K: Experimental cervical spondylosis in the mouse. Spine (Phila Pa 1976). 16(10 Suppl): S495–S500. 1991. View Article : Google Scholar : PubMed/NCBI
2	Mern DS, Beierfuss A, Thome C and Hegewald AN: Enhancing human nucleus pulposus cells for biological treatment approaches of degenerative intervertebral disc diseases: A systematic review. J Tissue Eng Regenerative Med. 8:925–936. 2014. View Article : Google Scholar
3	Wuertz K and Haglund L: Inflammatory mediators in intervertebral disk degeneration and discogenic pain. Global Spine J. 3:175–184. 2013. View Article : Google Scholar : PubMed/NCBI
4	Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, Bullock R, Isaacs RE, Brown C and Richardson WJ: Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 62:1974–1982. 2010.PubMed/NCBI
5	Akyol S, Eraslan BS, Etyemez H, Tanriverdi T and Hanci M: Cataboliccytokine expressions in patients with degenerative disc disease. Turk Neurosurg. 20:492–499. 2010.PubMed/NCBI
6	Le Maitre CL, Freemont AJ and Hoyland JA: The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 7:R732–R745. 2005. View Article : Google Scholar : PubMed/NCBI
7	Le Maitre CL, Hoyland JA and Freemont AJ: Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther. 9:R772007. View Article : Google Scholar : PubMed/NCBI
8	Risbud MV and Shapiro IM: Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nat Rev Rheumatol. 10:44–56. 2014. View Article : Google Scholar : PubMed/NCBI
9	Sutovsky J, Benco M, Sutovska M, Kocmalova M, Pappova L, Miklusica J, Frano A and Kurca E: Cytokine and chemokine profile changes in patients with lower segment lumbar degenerative spondylolisthesis. Int J Surg. 43:163–170. 2017. View Article : Google Scholar : PubMed/NCBI
10	Zhang Y, Zhao Y, Li J, Wang S, Liu Y, Nie L and Cheng L: Interleukin-9 Promotes TNF-α and PGE2 release in human degenerated intervertebral disc tissues. Spine (Phila Pa 1976). 41:1631–1640. 2016. View Article : Google Scholar : PubMed/NCBI
11	Schroeder GD, Markova DZ, Koerner JD, Rihn JA, Hilibrand AS, Vaccaro AR, Anderson DG and Kepler CK: Are Modic changes associated with intervertebral disc cytokine profiles? Spine J. 17:129–134. 2017. View Article : Google Scholar : PubMed/NCBI
12	Kuelling FA, Foley KT, Liu JJ, Liebenberg E, Sin AH, Matsukawa A and Lotz JC: The anabolic effect of plasma-mediated ablation on the intervertebral disc: Stimulation of proteoglycan and interleukin-8 production. Spine J. 14:2479–2487. 2014. View Article : Google Scholar : PubMed/NCBI
13	Wang YJ, Shi Q, Lu WW, Cheung KC, Darowish M, Li TF, Dong YF, Zhou CJ, Zhou Q, Hu ZJ, et al: Cervical intervertebral disc degeneration induced by unbalanced dynamic and static forces: A novel in vivo rat model. Spine (Phila Pa 1976). 31:1532–1538. 2006. View Article : Google Scholar : PubMed/NCBI
14	Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 27:1–550. 2009. View Article : Google Scholar : PubMed/NCBI
15	Dinarello CA: Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117:3720–3732. 2011. View Article : Google Scholar : PubMed/NCBI
16	Rosenzweig JM, Lei J and Burd I: Interleukin-1 receptor blockade in perinatal brain injury. Front Pediatr. 2:1082014. View Article : Google Scholar : PubMed/NCBI
17	Yang W, Yu XH, Wang C, He WS, Zhang SJ, Yan YG, Zhang J, Xiang YX and Wang WJ: Interleukin-1β in intervertebral disk degeneration. Clinica Chimica Acta. 450:1–272. 2015. View Article : Google Scholar
18	Smith LJ, Chiaro JA, Nerurkar NL, Cortes DH, Horava SD, Hebela NM, Mauck RL, Dodge GR and Elliott DM: Nucleus pulposus cells synthesize a functional extracellular matrix and respond to inflammatory cytokine challenge following long-term agarose culture. Eur Cell Mater. 22:291–301. 2011. View Article : Google Scholar : PubMed/NCBI
19	Sainoh T, Orita S, Miyagi M, Inoue G, Kamoda H, Ishikawa T, Yamauchi K, Suzuki M, Sakuma Y, Kubota G, et al: Single intradiscal administration of the tumor necrosis factor-alpha inhibitor, etanercept, for patients with discogenic low back pain. Pain Med. 17:40–45. 2016.PubMed/NCBI
20	Séguin CA, Pilliar RM, Roughley PJ and Kandel RA: Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine (Phila Pa 1976). 30:1940–1948. 2005. View Article : Google Scholar : PubMed/NCBI
21	Purmessur D, Freemont AJ and Hoyland JA: Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res Ther. 10:R992008. View Article : Google Scholar : PubMed/NCBI
22	Lai A, Moon A, Purmessur D, Skovrlj B, Laudier DM, Winkelstein BA, Cho SK, Hecht AC and Iatridis JC: Annular puncture with tumor necrosis factor-alpha injection enhances painful behavior with disc degeneration in vivo. Spine J. 16:420–431. 2015. View Article : Google Scholar : PubMed/NCBI
23	Lee S, Moon CS, Sul D, Lee J, Bae M, Hong Y, Lee M, Choi S, Derby R, Kim BJ, et al: Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem. 42:1504–1511. 2009. View Article : Google Scholar : PubMed/NCBI
24	Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG and Fitzpatrick JM: Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 84:196–201. 2002. View Article : Google Scholar : PubMed/NCBI
25	Starbeck-Miller GR, Xue HH and Harty JT: IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J Exp Med. 211:1–120. 2014. View Article : Google Scholar : PubMed/NCBI
26	Garcia K, Sun Z, Mattson E, Li L, Smyth K and Xiao Z: IL-12 is required for mTOR regulation of memory CTLs during viral infection. Genes Immun. 15:413–423. 2014. View Article : Google Scholar : PubMed/NCBI
27	Abdi K and Singh NJ: Singh Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines. Cytokine. 76:53–57. 2015. View Article : Google Scholar : PubMed/NCBI
28	Akyol S, Eraslan BS, Etyemez H, Tanriverdi T and Hanci M: Catabolic cytokine expressions in patients with degenerative disc disease. Turk Neurosurg. 20:492–499. 2010.PubMed/NCBI
29	Lin WP, Lin JH, Chen XW, Wu CY, Zhang LQ and Lai JM: Interleukin-10 promoter polymorphisms associated with susceptibility to lumbar disc degeneration in a Chinese cohort. Genetics Mol Res. 10:1719–1727. 2011. View Article : Google Scholar
30	Holm S, Mackiewicz Z, Holm AK, Konttinen YT, Kouri VP, Indahl A and Salo J: Pro-inflammatory, pleiotropic, and anti-inflammatory TNF-alpha, IL-6, and IL-10 in experimental porcine intervertebral disk degeneration. Vet Pathol. 46:1292–1300. 2009. View Article : Google Scholar : PubMed/NCBI
31	Li W, Liu T, Wu L, Chen C, Jia Z, Bai X and Ruan D: Blocking the function of inflammatory cytokines and mediators by using IL-10 and TGF-β: A potential biological immunotherapy for intervertebral disc degeneration in a beagle model. Int J Mol Sci. 15:17270–17283. 2014. View Article : Google Scholar : PubMed/NCBI
32	Maltman J, Pragnell IB and Graham GJ: Specificity and reciprocity in the interactions between TGF-beta and macrophage inflammatory protein-1 alpha. J Immunol. 156:1566–1571. 1996.PubMed/NCBI
33	Zhen G and Cao X: Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol Sci. 35:227–236. 2014. View Article : Google Scholar : PubMed/NCBI
34	Nishida K, Kang JD, Gilbertson LG, Moon SH, Suh JK, Vogt MT, Robbins PD and Evans CH: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Phila Pa 1976). 24:2419–2425. 1999. View Article : Google Scholar : PubMed/NCBI
35	Illien-Jünger S, Lu Y, Purmessur D, Mayer JE, Walter BA, Roughley PJ, Qureshi SA, Hecht AC and Iatridis JC: Detrimental effects of discectomy on intervertebral disc biology can be decelerated by growth factor treatment during surgery - a large animal organ culture mode. Spine J. 14:2724–2732. 2014. View Article : Google Scholar : PubMed/NCBI
36	Cho H, Lee S, Park SH, Huang J, Hasty KA and Kim SJ: Synergistic effect of combined growth factors in porcine intervertebral disc degeneration. Connect Tissue Res. 54:181–186. 2013. View Article : Google Scholar : PubMed/NCBI
37	Abbott RD, Purmessur D, Monsey RD, Brigstock DR, Laudier DM and Iatridis JC: Degenerative grade affects the responses of human nucleus pulposus cells to link-N, CTGF, and TGFβ3. J Spinal Disord Tech. 26:E86–E94. 2013. View Article : Google Scholar : PubMed/NCBI
38	Kishimoto T, Akira S, Narazaki M and Taga T: Interleukin-6 family of cytokines and gp130. Blood. 86:1243–1254. 1995.PubMed/NCBI
39	Gruol DL: IL-6 regulation of synaptic function in the CNS. Neuropharmacology. 96:42–54. 2015. View Article : Google Scholar : PubMed/NCBI
40	Gruol DL, Puro A, Hao C, Blakely P, Janneke E and Vo K: Neuroadaptive changes in cerebellar neurons induced by chronic exposure to IL-6. J Neuroimmunol. 239:28–36. 2011. View Article : Google Scholar : PubMed/NCBI
41	Sainoh T, Orita S, Miyagi M, Sakuma Y, Yamauchi K, Suzuki M, Kubota G, Oikawa Y, Inage K, Sato J, et al: Interleukin-6 and interleukin-6 receptor expression, localization and involvement in pain-sensing neuron activation in a mouse intervertebral disc injury mode. J Orthop Res. 33:1508–1514. 2015. View Article : Google Scholar : PubMed/NCBI
42	Miyagi M, Ishikawa T, Orita S, Eguchi Y, Kamoda H, Arai G, Suzuki M, Inoue G, Aoki Y, Toyone T, et al: Disk injury in rats produces persistent increases in pain-related neuropeptides in dorsal root ganglia and spinal cord glia but only transient increases in inflammatory mediators: Pathomechanism of chronic diskogenic low back pain. Spine (PhilaPa 1976). 36:2260–2266. 2011. View Article : Google Scholar
43	Xiang YJ, Shen XH, Shen Z, et al: Local inflammatory cytokine changes in degenerative vertebal discs in patients with cervical spondylotic myelopathy. Acad J Sec Mil Univ. 24:788–790. 2003.